1.26
Schlusskurs vom Vortag:
$1.26
Offen:
$1.26
24-Stunden-Volumen:
33,650
Relative Volume:
0.41
Marktkapitalisierung:
$10.98M
Einnahmen:
$6.74M
Nettoeinkommen (Verlust:
$-14.74M
KGV:
-0.5602
EPS:
-2.2491
Netto-Cashflow:
$-18.31M
1W Leistung:
-0.79%
1M Leistung:
+9.57%
6M Leistung:
+6.78%
1J Leistung:
-43.75%
Evogene Ltd Stock (EVGN) Company Profile
Vergleichen Sie EVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
EVGN
Evogene Ltd
|
1.26 | 10.98M | 6.74M | -14.74M | -18.31M | -2.2491 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-08 | Eingeleitet | ROTH Capital | Buy |
| 2021-07-29 | Eingeleitet | Aegis Capital | Buy |
| 2020-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2013-12-16 | Eingeleitet | Oppenheimer | Outperform |
Evogene Ltd Aktie (EVGN) Neueste Nachrichten
How strong is Evogene Ltd. stock revenue growth2025 Big Picture & Safe Entry Zone Identification - newser.com
Technical analysis overview for Evogene Ltd. stockPortfolio Return Report & Accurate Buy Signal Notifications - newser.com
Real time social sentiment graph for Evogene Ltd.Market Performance Report & Free Long-Term Investment Growth Plans - newser.com
Relative strength of Evogene Ltd. in sector analysisWeekly Profit Recap & Pattern Based Trade Signal System - newser.com
How to forecast Evogene Ltd. trends using time seriesWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
What does recent volatility data suggest for Evogene Ltd.Portfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Evogene Ltd. stock prediction for this weekPortfolio Value Summary & Risk Managed Investment Signals - newser.com
Is Evogene Ltd. stock attractive for retirement portfoliosJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Will Evogene Ltd. stock gain from strong economyMarket Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Candlestick signals on Evogene Ltd. stock todayJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
What earnings revisions data tells us about Evogene Ltd.Weekly Gains Report & Accurate Intraday Trade Tips - newser.com
How to monitor Evogene Ltd. with trend dashboardsBull Run & Weekly Top Gainers Trade List - newser.com
Using Python tools to backtest Evogene Ltd. strategiesJuly 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Is Evogene Ltd. stock a defensive play in 2025July 2025 Institutional & Weekly High Potential Stock Alerts - newser.com
What technical models suggest about Evogene Ltd.’s comebackGold Moves & AI Driven Stock Movement Reports - newser.com
Is Evogene Ltd. forming a reversal pattern2025 Risk Factors & Growth Focused Investment Plans - newser.com
Institutional scanner results for Evogene Ltd.Weekly Gains Summary & Safe Entry Point Identification - newser.com
Can Evogene Ltd. stock withstand economic slowdownQuarterly Risk Review & Technical Entry and Exit Tips - newser.com
Custom strategy builders for tracking Evogene Ltd.July 2025 Action & Weekly High Potential Alerts - newser.com
How to manage a losing position in Evogene Ltd.Quarterly Growth Report & Technical Buy Zone Confirmations - newser.com
How Evogene Ltd. stock benefits from tech adoptionJuly 2025 Setups & High Accuracy Investment Signals - newser.com
Finanzdaten der Evogene Ltd-Aktie (EVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):